• 1
    de Graaf R, Bijl RV, Spijker J, Beekman AT, Vollebergh WA. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Soc. Psychiatry Psychiatr. Epidemiol. 2003; 38: 111.
  • 2
    Stinson FS, Grant BF, Dawson DA, Ruan WJ, Huang B, Saha T. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2005; 80: 105116.
  • 3
    Degenhardt L, Bucello C, Calabria B et al. What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug Alcohol Depend. 2011; 117: 85101.
  • 4
    Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012; 379: 5570.
  • 5
    Dawson DA, Grant BF, Stinson FS, Chou PS. Psychopathology associated with drinking and alcohol use disorders in the college and general adult populations. Drug Alcohol Depend. 2005; 77: 139150.
  • 6
    Grant BF, Stinson FS, Dawson DA, Chou SP, Ruan WJ. Co-occurrence of DSM-IV personality disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Compr. Psychiatry 2005; 46: 15.
  • 7
    Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the national comorbidity survey. Arch. Gen. Psychiatry 1997; 54: 313321.
  • 8
    Compton WM, Conway KP, Stinson FS, Colliver JD, Grant BF. Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. J. Clin. Psychiatry 2005; 66: 677685.
  • 9
    Kessler RC, Adler LA, Barkley R et al. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: Results from the national comorbidity survey replication. Biol. Psychiatry 2005; 57: 14421451.
  • 10
    Strakowski SM, DelBello MP, Fleck DE et al. Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania. Arch. Gen. Psychiatry 2005; 62: 851858.
  • 11
    Wiesner M, Kim HK, Capaldi DM. Developmental trajectories of offending: Validation and prediction to young adult alcohol use, drug use, and depressive symptoms. Dev. Psychopathol. 2005; 17: 251270.
  • 12
    Fu Q, Heath AC, Bucholz KK et al. Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: Contribution of antisocial personality disorder in men. Arch. Gen. Psychiatry 2002; 59: 11251132.
  • 13
    Houston RJ, Bauer LO, Hesselbrock VM. Depression and familial risk for substance dependence: A P300 study of young women. Psychiatry Res. 2003; 124: 4962.
  • 14
    Lieb R, Merikangas KR, Hofler M, Pfister H, Isensee B, Wittchen HU. Parental alcohol use disorders and alcohol use and disorders in offspring: A community study. Psychol. Med. 2002; 32: 6378.
  • 15
    Nurnberger JI, Jr, Wiegand R, Bucholz K et al. A family study of alcohol dependence: Coaggregation of multiple disorders in relatives of alcohol-dependent probands. Arch. Gen. Psychiatry 2004; 61: 12461256.
  • 16
    Bailey JA, McCloskey LA. Pathways to adolescent substance use among sexually abused girls. J. Abnorm. Child Psychol. 2005; 33: 3953.
  • 17
    DuBois DL, Silverthorn N. Do deviant peer associations mediate the contributions of self-esteem to problem behavior during early adolescence? A 2-year longitudinal study. J. Clin. Child Adolesc. Psychol. 2004; 33: 382388.
  • 18
    Li F, Barrera M, Jr, Hops H, Fisher KJ. The longitudinal influence of peers on the development of alcohol use in late adolescence: A growth mixture analysis. J. Behav. Med. 2002; 25: 293315.
  • 19
    Merikangas KR, Stolar M, Stevens DE et al. Familial transmission of substance use disorders. Arch. Gen. Psychiatry 1998; 55: 973979.
  • 20
    Compton WM, Thomas YF, Conway KP, Colliver JD. Developments in the epidemiology of drug use and drug use disorders. Am. J. Psychiatry 2005; 162: 14941502.
  • 21
    Henquet C, Murray R, Linszen D, van Os J. The environment and schizophrenia: The role of cannabis use. Schizophr. Bull. 2005; 31: 608612.
  • 22
    Windle M, Wiesner M. Trajectories of marijuana use from adolescence to young adulthood: Predictors and outcomes. Dev. Psychopathol. 2004; 16: 10071027.
  • 23
    Goodwin RD, Fergusson DM, Horwood LJ. Association between anxiety disorders and substance use disorders among young persons: Results of a 21-year longitudinal study. J. Psychiatr. Res. 2004; 38: 295304.
  • 24
    Johnson JG, Cohen P, Pine DS, Klein DF, Kasen S, Brook JS. Association between cigarette smoking and anxiety disorders during adolescence and early adulthood. JAMA 2000; 284: 23482351.
  • 25
    Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 1994; 51: 819.
  • 26
    Kessler RC, Little RJ, Groves RM. Advances in strategies for minimizing and adjusting for survey nonresponse. Epidemiol. Rev. 1995; 17: 192204.
  • 27
    Wittchen HU. Reliability and validity studies of the WHO–Composite International Diagnostic Interview (CIDI): A critical review. J. Psychiatr. Res. 1994; 28: 5784.
  • 28
    Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey. Am. J. Psychiatry 1994; 151: 979986.
  • 29
    Wittchen HU, Kessler RC, Zhao S, Abelson J. Reliability and clinical validity of UM-CIDI DSM-III-R generalized anxiety disorder. J. Psychiatr. Res. 1995; 29: 95110.
  • 30
    Wittchen HU, Zhao S, Abelson JM, Abelson JL, Kessler RC. Reliability and procedural validity of UM-CIDI DSM-III-R phobic disorders. Psychol. Med. 1996; 26: 11691177.
  • 31
    Deacon BJ, Valentiner DP. Substance use and non-clinical panic attacks in a young adult sample. J. Subst. Abuse 2000; 11: 715.
  • 32
    O'Brien MS, Wu LT, Anthony JC. Cocaine use and the occurrence of panic attacks in the community: A case-crossover approach. Subst. Use Misuse 2005; 40: 285297.
  • 33
    Valentiner DP, Mounts NS, Deacon BJ. Panic attacks, depression and anxiety symptoms, and substance use behaviors during late adolescence. J. Anxiety Disord. 2004; 18: 573585.
  • 34
    Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. Am. J. Psychiatry 2000; 157: 493505.
  • 35
    Stein DJ, Goodman WK, Rauch SL. The cognitive-affective neuroscience of obsessive-compulsive disorder. Curr. Psychiatry Rep. 2000; 2: 341346.
  • 36
    Schneier FR, Liebowitz MR, Abi-Dargham A, Zea-Ponce Y, Lin SH, Laruelle M. Low dopamine D(2) receptor binding potential in social phobia. Am. J. Psychiatry 2000; 157: 457459.
  • 37
    Volkow ND, Fowler JS, Wang GJ, Swanson JM. Dopamine in drug abuse and addiction: Results from imaging studies and treatment implications. Mol. Psychiatry 2004; 9: 557569.
  • 38
    Chartier MJ, Walker JR, Stein MB. Considering comorbidity in social phobia. Soc. Psychiatry Psychiatr. Epidemiol. 2003; 38: 728734.
  • 39
    Zimmermann G, Pin MA, Krenz S et al. Prevalence of social phobia in a clinical sample of drug dependent patients. J. Affect. Disord. 2004; 83: 8387.
  • 40
    Sonntag H, Wittchen HU, Hofler M, Kessler RC, Stein MB. Are social fears and DSM-IV social anxiety disorder associated with smoking and nicotine dependence in adolescents and young adults? Eur. Psychiatry 2000; 15: 6774.